NSRX Stock Summary and Trading Ideas (Nasus Pharma Ltd. | AMEX:NSRX)

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Nasus Pharma Ltd. trades on the AMEX stock market under the symbol NSRX.

As of October 6, 2026, NSRX stock price declined to $3.84 with 17,197 million shares trading.

NSRX has a beta of 1.35, meaning it tends to be more sensitive to market movements. NSRX has a correlation of 0.03 to the broad based SPY ETF.

NSRX has a market cap of $44.97 million. This is considered a Sub-Micro Cap stock.

NSRX has underperformed the market in the last year with a return of -45.5%, while SPY returned +17.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NSRX shares. However, NSRX has outperformed the market in the last 3 month and 2 week periods, returning +11.8% and +7.6%, while SPY returned +4.0% and +0.7%, respectively. This indicates NSRX has been having a stronger performance recently.

NSRX support price is $3.58 and resistance is $4.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NSRX shares will trade within this expected range on the day.